Evidence map›Paper›PMID 35879310›Full record

ArticleNature communications2022

Dysfunctional ERG signaling drives pulmonary vascular aging and persistent fibrosis.

Nunzia Caporarello, Jisu Lee, Tho X Pham, Dakota L Jones, Jiazhen Guan, Patrick A Link, Jeffrey A Meridew, Grace Marden, Takashi Yamashita, Collin A Osborne and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 82 citations in OpenAlex.

  1. Angiogenesis in Lung Regeneration and Aging.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Endothelial Heterogeneity in Pulmonary Hypertension.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Nunzia Caporarello *Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-3183-2868
Jisu Lee *Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Tho X PhamDepartment of Medicine, Boston University School of Medicine, Boston, MA, USA.
Dakota L JonesDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Jiazhen GuanDepartment of Medicine, Boston University School of Medicine, Boston, MA, USA.
Patrick A LinkDepartment of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0003-1847-8857
Jeffrey A MeridewDepartment of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Grace MardenDepartment of Medicine, Boston University School of Medicine, Boston, MA, USA.
Takashi YamashitaDepartment of Medicine, Boston University School of Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0003-2810-1834
Collin A OsborneDepartment of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Aditya V BhagwateDepartment of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Steven K HuangDepartment of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Roberto F NicosiaDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Daniel J TschumperlinDepartment of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Maria TrojanowskaDepartment of Medicine, Boston University School of Medicine, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9550-7178
Giovanni LigrestiDepartment of Medicine, Boston University School of Medicine, Boston, MA, USA. ligresti@bu.edu.ORCID http://orcid.org/0000-0002-3375-8665
Boston University · USMayo Clinic in Florida · USUniversity of Michigan · USUniversity of Pennsylvania · USUniversity of Washington · US

Funding

BIOLOGY OF THE LUNG--MULTIDISCIPLINARY PROGRAMT32HL007035 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton, JOSEPH P MIZGERD · 1985 to 2026
$24.3M
Translational studies for identifying and targeting novel pathways in systemic sclerosis pathogenesisP50AR060780 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LAFYATIS, ROBERT A. · 2011 to 2021
$14.9M
Mechanobiology of Lung FibrosisR01HL092961 · NHLBI · MAYO CLINIC ROCHESTER · PI Daniel J. Tschumperlin · 2009 to 2026
$8.0M
The molecular mechanisms of fibrosisR01AR042334 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TROJANOWSKA, MARIA · 1994 to 2018
$5.2M
The Role of KCNMB1 and the Large Conductance Potassium (BK) Channel in Myofibroblast Differentiation and Pulmonary FibrosisR01HL127203 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HUANG, STEVEN K · 2015 to 2024
$4.4M
Interdisciplinary Training in Lung Physiology and Biomedical EngineeringT32HL105355 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S., SIECK, GARY C. · 2012 to 2021
$3.9M
Epigenetic regulation of pulmonary fibrosisR01HL142596 · NHLBI · MAYO CLINIC ROCHESTER · PI Giovanni Ligresti · 2018 to 2026
$2.9M
Targeting vascular dysfunction to promote lung repair and fibrosis resolutionR01HL158733 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LIGRESTI, GIOVANNI · 2022 to 2025
$2.8M
GATA-6 in pulmonary arterial hypertensionR01HL150638 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GONCHAROVA, ELENA, TROJANOWSKA, MARIA · 2020 to 2023
$2.6M
NHLBI NIH HHS R01 HL092961NHLBI NIH HHS R01 HL127203NHLBI NIH HHS R01 HL142596NHLBI NIH HHS R01 HL150638NHLBI NIH HHS R01 HL158733NHLBI NIH HHS T32 HL007035NHLBI NIH HHS T32 HL105355NIAMS NIH HHS P50 AR060780NIAMS NIH HHS R01 AR042334
6 · The paper itself

Abstract

Vascular dysfunction is a hallmark of chronic diseases in elderly. The contribution of the vasculature to lung repair and fibrosis is not fully understood. Here, we performed an epigenetic and transcriptional analysis of lung endothelial cells (ECs) from young and aged mice during the resolution or progression of bleomycin-induced lung fibrosis. We identified the transcription factor ETS-related gene (ERG) as putative orchestrator of lung capillary homeostasis and repair, and whose function is dysregulated in aging. ERG dysregulation is associated with reduced chromatin accessibility and maladaptive transcriptional responses to injury. Loss of endothelial ERG enhances paracrine fibroblast activation in vitro, and impairs lung fibrosis resolution in young mice in vivo. scRNA-seq of ERG deficient mouse lungs reveales transcriptional and fibrogenic abnormalities resembling those associated with aging and human lung fibrosis, including reduced number of general capillary (gCap) ECs. Our findings demonstrate that lung endothelial chromatin remodeling deteriorates with aging leading to abnormal transcription, vascular dysrepair, and persistent fibrosis following injury.

Indexed as

Pulmonary FibrosisAgedAgingAnimalsBleomycinEndothelial CellsFibrosisHumansLungMiceSignal TransductionTranscriptional Regulator ERGBleomycinERG protein, humanTranscriptional Regulator ERG

Identifiers

PMID35879310
PMCPMC9314350
OpenAlexW4287307853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.